Edition:
United States

Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

74.68USD
22 Feb 2019
Change (% chg)

$0.65 (+0.88%)
Prev Close
$74.03
Open
$74.15
Day's High
$74.83
Day's Low
$74.15
Volume
477,573
Avg. Vol
990,260
52-wk High
$78.36
52-wk Low
$61.06

Chart for

About

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $39,394.40
Shares Outstanding(Mil.): 532.14
Dividend: 0.19
Yield (%): 1.03

Financials

  BAX.N Industry Sector
P/E (TTM): 24.78 33.92 35.95
EPS (TTM): 2.99 -- --
ROI: -- 12.44 12.64
ROE: -- 14.71 13.82

U.S. closes IV solution shortage antitrust probe, Baxter says

Baxter International Inc said the U.S. Justice Department has closed an antitrust probe examining possible communication among producers of intravenous saline solutions during supply shortages that created higher prices.

Feb 22 2019

U.S. closes IV solution shortage antitrust probe, Baxter says

Feb 22 Baxter International Inc said the U.S. Justice Department has closed an antitrust probe examining possible communication among producers of intravenous saline solutions during supply shortages that created higher prices.

Feb 22 2019

Smiths and ICU Medical healthcare merger talks collapse

British engineering firm Smiths Group Plc said on Thursday talks with U.S.-based ICU Medical Inc over a possible 7 billion pound-plus ($9.2 billion) merger of their healthcare businesses had fallen through.

Sep 13 2018

Earnings vs. Estimates